Cita APA (7a ed.)
M, P., EA, S., H, G., EO, A., Perumal, M., Stronach, E. A., . . . Aboagye, E. O. (2012). Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose- and 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography as biomarkers of therapy response in platinum-resistant ovarian cancer. Molecular Imaging & Biology, 14(6), 753-762.
Cita Chicago Style (17a ed.)
M, Perumal, Stronach EA, Gabra H, Aboagye EO, Meg Perumal, Euan A. Stronach, Hani Gabra, y Eric O. Aboagye. "Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose- and 3'-deoxy-3'-[18F]fluorothymidine-positron Emission Tomography as Biomarkers of Therapy Response in Platinum-resistant Ovarian Cancer." Molecular Imaging & Biology 14, no. 6 (2012): 753-762.
Cita MLA (9a ed.)
M, Perumal, et al. "Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose- and 3'-deoxy-3'-[18F]fluorothymidine-positron Emission Tomography as Biomarkers of Therapy Response in Platinum-resistant Ovarian Cancer." Molecular Imaging & Biology, vol. 14, no. 6, 2012, pp. 753-762.
Precaución: Estas citas no son 100% exactas.